DENNIS BRENNER
Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology WEST ORANGE, NJ NPI 1467487512
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology NJ Neurocrine BioSciences, Inc. All categories
General Payments — all program years on this page
$21,599.71
- Category: General Payments
- Program years: PY2018–2024
- Record count: 418
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $6,675.02 across 64 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,500.00 | 1 |
| Food and Beverage | $1,666.02 | 62 |
| Travel and Lodging | $509.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $4,525.45 | 3 |
| PFIZER INC. | $688.73 | 6 |
| Novo Nordisk AS | $453.82 | 9 |
| SANOFI-AVENTIS U.S. LLC | $282.24 | 8 |
| BioMarin Pharmaceutical Inc. | $111.22 | 5 |
| Alexion Pharmaceuticals, Inc. | $109.62 | 5 |
| Ascendis Pharma Inc | $83.05 | 5 |
| ABBVIE INC. | $57.84 | 4 |
| Tandem Diabetes Care, Inc. | $53.18 | 2 |
| Azurity Pharmaceuticals, Inc. | $47.12 | 3 |
| Abbott Laboratories | $45.43 | 2 |
| Insulet Corporation | $44.33 | 2 |
| DEXCOM, INC. | $41.48 | 2 |
| Amphastar Pharmaceuticals, Inc. | $33.09 | 2 |
| TOLMAR, INC. | $21.96 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $16.99 | 1 |
| JAZZ PHARMACEUTICALS INC. | $16.35 | 1 |
| Kyowa Kirin, Inc. | $15.34 | 1 |
| Rhythm Pharmaceuticals, Inc. | $14.68 | 1 |
| Endo USA, Inc. | $13.10 | 1 |
By program year
Records — PY2024 (64)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.